ECM
PFE icon

ExodusPoint Capital Management’s Pfizer PFE Stock Holding History

ExodusPoint Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-816,068
Closed -$22.9M – 1948
2026
Q1 		$22.9M Sell
816,068
-666,483
-45% -$17.7M 0.18% 79
2025
Q4 		$36.9M Buy
1,482,551
+993,496
+203% +$25.1M 0.29% 42
2025
Q3 		$12.5M Buy
+489,055
New +$12.1M 0.13% 152
2025
Q2 		– Sell
-1,879,326
Closed -$47.6M – 1869
2025
Q1 		$47.6M Buy
+1,879,326
New +$49.2M 0.47% 27
2024
Q4 		– Sell
-8,884
Closed -$241K – 1927
2024
Q3 		$257K Sell
8,884
-467,113
-98% -$13.6M ﹤0.01% 1402
2024
Q2 		$13.3M Buy
+475,997
New +$13.1M 0.09% 202
2023
Q4 		– Sell
-1,261,820
Closed -$41.9M – 1916
2023
Q3 		$41.9M Buy
1,261,820
+1,245,437
+7,602% +$44M 0.4% 41
2023
Q2 		$601K Sell
16,383
-142,691
-90% -$5.55M ﹤0.01% 1291
2023
Q1 		$6.49M Buy
159,074
+83,397
+110% +$3.6M 0.05% 422
2022
Q4 		$3.88M Sell
75,677
-93,899
-55% -$4.5M 0.06% 418
2022
Q3 		$7.42M Buy
+169,576
New +$8.24M 0.1% 283
2022
Q2 		– Sell
-102,096
Closed -$5.29M – 2328
2022
Q1 		$5.29M Sell
102,096
-216,532
-68% -$11.2M 0.07% 373
2021
Q4 		$18.8M Buy
318,628
+25,556
+9% +$1.27M 0.19% 83
2021
Q3 		$12.6M Buy
+293,072
New +$13M 0.17% 143
2021
Q1 		– Sell
-222,039
Closed -$8.17M – 2485
2020
Q4 		$8.17M Buy
222,039
+182,168
+457% +$6.68M 0.08% 154
2020
Q3 		$1.39M Sell
39,871
-136,192
-77% -$4.77M 0.03% 545
2020
Q2 		$5.46M Buy
176,063
+143,481
+440% +$4.87M 0.14% 144
2020
Q1 		$1.01M Sell
32,582
-33,968
-51% -$1.16M 0.06% 306
2019
Q4 		$2.47M Buy
+66,550
New +$2.37M 0.05% 290
2019
Q3 		– Sell
-6,429
Closed -$264K – 1563
2019
Q2 		$264K Sell
6,429
-223,299
-97% -$8.87M 0.01% 763
2019
Q1 		$9.26M Buy
+229,728
New +$9.2M 0.69% 22

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ExodusPoint Capital Management's PFE Position: Q2 2026 in Review

ExodusPoint Capital Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 816,068 shares — an estimated $22.9M sold.

ExodusPoint Capital Management first reported a position in PFE in Q1 2019 and held it in 21 quarters. The position peaked at $47.6M in Q1 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • ExodusPoint Capital Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 816,068 Pfizer shares in Q2 2026, an estimated $22.9M.
  • ExodusPoint Capital Management first reported a position in Pfizer in Q1 2019 and held it in 21 quarters.
  • ExodusPoint Capital Management's Pfizer position peaked at $47.6M in Q1 2025.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.